|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 119.24 CHF | +0.59% |
|
+2.09% | +8.80% |
| 04:06am | Can Bayer Still Recover? | |
| 01:19am | Novartis: Pluvicto psmaddition data to highlight efficacy in metastatic hormone-sensitive prostate cancer | RE |
Chart calendar Novartis AG
Upcoming events on Novartis AG
| 2026-07-21 | Earnings release - Q2 2026 | |
| 2026-10-26 | Earnings release - Q3 2026 | Day |
Past events on Novartis AG
| 2026-04-28 | Earnings release - Q1 2026 | |
| 2026-04-28 | Earnings presentation | 08:00 |
| 2026-03-06 | Annual General Meeting | 04:00 |
| 2026-03-06 | Présentation aux Actionnaires / Analystes | 04:00 |
| 2026-02-04 | Earnings presentation | 08:00 |
| 2026-02-03 | Earnings release - Q4 2025 | Day |
| 2025-12-01 | Information meeting | 10:00 |
| 2025-11-20 | Présentation aux Actionnaires / Analystes | 04:15 |
| 2025-11-20 | Présentation aux Actionnaires / Analystes | 03:00 |
| 2025-10-30 | Information meeting | 11:30 |
| 2025-10-28 | Earnings presentation | 09:00 |
| 2025-10-27 | Earnings release - Q3 2025 | Day |
| 2025-07-17 | Earnings presentation | 08:00 |
| 2025-07-16 | Earnings release - Q2 2025 | Day |
Past dividends on Novartis AG
| 2026-03-10 | Ex-dividend date - 3.7 CHF | 00:00 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 46 660 46 810 -0.32% | 51 722 50 407 2.61% | 56 674 55 618 1.9% | 57 124 | 60 577 | 64 405 |
|
EBITDA Million USD | Released Forecast Spread | 17 937 18 223 -1.57% | 21 006 19 819 5.99% | 23 415 23 671 -1.08% | 23 485 | 25 355 | 27 612 |
|
EBIT Million USD | Released Forecast Spread | 16 372 16 735 -2.17% | 19 494 18 983 2.69% | 21 889 21 846 0.19% | 21 536 | 23 343 | 25 323 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 9 123 10 323 -11.63% | 13 640 13 560 0.59% | 16 352 17 360 -5.81% | 15 751 | 18 324 | 20 209 |
|
Net income Million USD | Released Forecast Spread | 14 854 10 329 43.8% | 11 939 11 438 4.38% | 13 967 14 570 -4.14% | 14 149 | 15 685 | 17 564 |
|
EPS USD | Released Forecast Spread | 7,15 5,38 32.95% | 5,92 5,53 7% | 7,21 7,16 0.7% | 7,20 | 8,42 | 9,60 |
| Announcement Date | 31/01/24 | 31/01/25 | 04/02/26 | - |
Quarterly results
| Fiscal Period | March | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 13 172 12 666 4% | 13 558 12 823 5.73% | 13 620 13 116 3.85% | 14 836 14 136 4.95% | 14 358 13 866 3.55% | 13 860 14 077 -1.54% | 13 524 13 480 0.33% | 14 230 | 14 618 | 15 032 |
|
EBITDA Million USD | Released Forecast Spread | 5 294 | 5 338 4 861 9.81% | ||||||||
|
EBIT Million USD | Released Forecast Spread | 5 145 4 892 5.16% | 4 859 4 435 9.56% | 5 575 5 272 5.75% | 5 925 5 827 1.68% | 5 460 5 520 -1.08% | 4 929 5 010 -1.62% | 4 897 5 215 -6.1% | 5 424 | 5 666 | 5 598 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 3 385 4 028 -15.96% | 3 285 3 478 -5.55% | 4 196 4 238 -0.99% | |||||||
|
Net income Million USD | Released Forecast Spread | 3 189 3 197 -0.25% | 2 820 2 585 9.08% | 3 606 3 255 10.78% | 4 024 3 909 2.93% | 3 930 3 652 7.61% | 2 404 2 414 -0.4% | 3 156 3 227 -2.21% | 3 310 | 3 287 | 3 519 |
|
EPS USD | Released Forecast Spread | 1,58 1,48 7.03% | 1,42 1,30 9.63% | 1,83 1,65 10.96% | 2,07 1,99 3.77% | 2,04 1,87 9.02% | 1,26 1,26 0.23% | 1,65 1,68 -2.07% | 1,73 | 1,72 | 1,86 |
| Announcement Date | 29/10/24 | 31/01/25 | 29/04/25 | 17/07/25 | 28/10/25 | 04/02/26 | 28/04/26 | - | - | - |
| 2026-05-21 | Board of Directors Meeting | Day | |
| 2026-05-21 | Présentation aux Actionnaires / Analystes | 20:30 | |
| 2026-05-21 | Earnings presentation | 23:00 | |
| 2026-05-21 | Annual General Meeting | 22:30 | |
| 2026-05-21 | Earnings release - Annual 2026 | Day | |
| 2026-05-21 | Board of Directors Meeting | Day | |
| 2026-05-21 | Board of Directors Meeting | Day | |
| 2026-05-21 | Annual General Meeting | 21:30 | |
| 2026-05-21 | Earnings presentation | 21:00 | |
| 2026-05-22 | Ex-dividend date - 0.12 USD | 00:00 |
Past sector events for Novartis AG
| Today | Earnings release - Q4 2026 | ||
| Today | Board of Directors Meeting | 07:00 | |
| Today | Earnings presentation | 03:00 | |
| Today | Annual General Meeting | 02:30 | |
| Today | Annual General Meeting | 02:00 | |
| Today | Annual General Meeting | 02:30 | |
| Today | Annual General Meeting | 09:00 | |
| Today | Présentation aux Actionnaires / Analystes | 09:00 | |
| Today | Annual General Meeting | 02:30 | |
| Today | Annual General Meeting | 02:30 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NOVN Stock
- Calendar Novartis AG
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















